Trial intelligence / Profile preview

Susceptibility changes among oral microorganisms following single-dose amoxicillin prophylaxis

2013-000405-23Phase 3Active

Sponsor
Karolinska University Hospital
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of amoxicillin in bacterial disease, sponsored by Karolinska University Hospital. Primary endpoint: Quantitative and qualitative changes in the oral microflora. Started Apr 2013; status: active.

02

Drugs

amoxicillin
03

Conditions

bacterial disease

Beyond the preview

Go deeper on 2013-000405-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000405-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call